Applied DNA Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$4.50 | -$4.50 | -$4.50 |
| Q2 2024 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2024 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2024 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q1 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
Applied DNA Sciences, Inc. Earnings Date And Information
Applied DNA Sciences, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $-0.35 by $0.82. The company had revenue of 797,519 for the quarter and had revenue of 13.37 M for the year. Applied DNA Sciences, Inc. has generated $-15 earnings per share over the last year ($-15.21 diluted earnings per share) and currently has a price-to-earnings ratio of -0.09. Applied DNA Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 18th, 2024 based on prior year's report dates.
Applied DNA Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q3 2024 | -$0.35 | $0.47 | 0.82 | $1.08 M | $797,519 |
| 05/10/2024 | Q2 2024 | -$4.60 | -$5.13 | -0.53 | $929,631 | |
| 02/08/2024 | Q1 2024 | -$6.20 | -$1.80 | 4.4 | $891,164 | |
| 01/26/2024 | Q4 2023 | -$5.29 | $1.68 M | $779,736 | ||
| 08/10/2023 | Q3 2023 | -$4.80 | -$4.80 | 0 | $2.56 M | $2.92 M |
| 05/11/2023 | Q2 2023 | -$3.40 | $0.91 | 4.31 | $4.41 M | |
| 02/09/2023 | Q1 2023 | -$6.60 | -$6.00 | 0.6 | $5.26 M | |
| 01/27/2023 | Q4 2022 | -$1.37 | $4.10 M | $3.56 M | ||
| 08/11/2022 | Q3 2022 | -$7.20 | -$0.13 | 7.07 | $3.60 M | $4.30 M |
| 05/12/2022 | Q2 2022 | -$6.00 | -$2.79 | 3.21 | $6.15 M | |
| 02/10/2022 | Q1 2022 | -$3.80 | -$12.61 | -8.81 | $4.17 M | |
| 01/28/2022 | Q4 2021 | -$12.04 | $2.30 M | $3.04 M | ||
| 08/12/2021 | Q3 2021 | -$4.80 | -$9.53 | -4.73 | $3.13 M | $1.70 M |
| 05/13/2021 | Q2 2021 | -$3.60 | -$4.19 | -0.59 | $2.67 M | |
| 02/11/2021 | Q1 2021 | -$11.00 | -$17.62 | -6.62 | $1.62 M | |
| 12/17/2020 | Q4 2020 | -$16.04 | $707,500 | $313,989 | ||
| 08/06/2020 | Q3 2020 | -$12.40 | -$14.37 | -1.97 | $802,000 | $431,516 |
| 05/14/2020 | Q2 2020 | -$0.77 | -$15.71 | -14.94 | $552,473 | |
| 02/06/2020 | Q1 2020 | -$1.24 | -$22.37 | -21.13 | $633,519 | |
| 01/27/2020 | Q4 2019 | -$23.00 | $2.11 M | $1.67 M |
Applied DNA Sciences, Inc. Earnings: Frequently Asked Questions
-
When is Applied DNA Sciences, Inc.'s earnings date?
Applied DNA Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, December 18th, 2024 based off last year's report dates.
-
Did Applied DNA Sciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Applied DNA Sciences, Inc. (:APDN) reported $0.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.35 by $0.82.
-
How can I listen to Applied DNA Sciences, Inc.'s earnings conference call?
The conference call for Applied DNA Sciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Applied DNA Sciences, Inc.'s conference call transcript?
The conference call transcript for Applied DNA Sciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Applied DNA Sciences, Inc. generate each year?
Applied DNA Sciences, Inc. (:APDN) has a recorded annual revenue of $13.37 M.
-
How much profit does Applied DNA Sciences, Inc. generate each year?
Applied DNA Sciences, Inc. (:APDN) has a recorded net income of $13.37 M. Applied DNA Sciences, Inc. has generated $-15.21 earnings per share over the last four quarters.
-
What is Applied DNA Sciences, Inc.'s price-to-earnings ratio?
Applied DNA Sciences, Inc. (:APDN) has a price-to-earnings ratio of -0.09 and price/earnings-to-growth ratio is -0.
